STOCK-BASED COMPENSATION PLAN (Details) (USD $) | 3 Months Ended | 12 Months Ended | 1 Months Ended |
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | Jan. 31, 2015 |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Number of options granted | 0 | 0 | | |
Fair value per share (in dollars per share) | $26.13 | | | |
Expected volatility, measurement period | 3 years | | | |
Service period of shares (in years) | 3 years | | | |
Cost | $985,000 | $739,000 | | |
Capitalized | -91,000 | -70,000 | | |
Net Expense | 894,000 | 669,000 | | |
Unrecognized compensation cost of awards granted under the plan | 6,800,000 | | | |
Weighted average period over which unrecognized compensation cost is to be recognized (in years) | 2 years 1 month 6 days | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-beginning balance (in dollars per share) | $24.40 | | | 24.4 |
Weighted average fair value nonvested shares-granted during the period (in dollars per share) | $28.69 | | | |
Weighted average fair value nonvested shares-cancelled/forfeited during the period (in dollars per share) | $24.13 | | | |
Weighted average fair value nonvested shares-vested during the period (in dollars per share) | $27.26 | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $26.13 | | | |
Officers and Key Employees | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Number of shares granted | 151,354 | 136,526 | | |
Vesting period of shares (in years) | 3 years | | | |
The range of the actual amount of shares that ultimately vest of the original share units granted (in hundredths) | 0% to 200% | | | |
Shares outstanding (in shares) | 374,766 | | 223,876 | |
Cost | 799,000 | 581,000 | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, beginning balance (in shares) | 223,876 | | | 223,876 |
Granted (in shares) | 151,354 | 136,526 | | |
Cancelled/Forfeited (in shares) | -464 | | | |
Vested (in shares) | 0 | | | |
Nonvested shares outstanding, ending balance (in shares) | 374,766 | | 223,876 | |
Additional disclosures [Abstract] | | | | |
Number of shares awarded during the period | 0 | | 0 | |
Officers and Key Employees | Grant Date January 2013 - TSR | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 49,514 | | | |
Fair value per share (in dollars per share) | $22.19 | | | |
Expected volatility (in hundredths) | 21.10% | | | |
Risk-free interest rate (in hundredths) | 0.40% | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 49,514 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $22.19 | | | |
Officers and Key Employees | Grant Date January 2013 - EPS | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 49,514 | | | |
Fair value per share (in dollars per share) | $25.59 | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 49,514 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $25.59 | | | |
Officers and Key Employees | Grant Date January 2014, TSR | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 62,192 | | | |
Fair value per share (in dollars per share) | $21.31 | | | |
Expected volatility (in hundredths) | 20.00% | | | |
Risk-free interest rate (in hundredths) | 0.80% | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 62,192 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $21.31 | | | |
Officers and Key Employees | Grant Date January 2014, EPS | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 62,192 | | | |
Fair value per share (in dollars per share) | $27.22 | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 62,192 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $27.22 | | | |
Officers and Key Employees | Grant Date January 2015, TSR | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 42,378 | | | |
Fair value per share (in dollars per share) | $26.31 | | | |
Expected volatility (in hundredths) | 16.00% | | | |
Risk-free interest rate (in hundredths) | 1.10% | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 42,378 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $26.31 | | | |
Officers and Key Employees | Grant Date January 2015, EPS, ROE, Time | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 108,976 | | | |
Fair value per share (in dollars per share) | $29.47 | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 108,976 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $29.47 | | | |
Director | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Number of shares granted | 25,398 | 23,220 | | |
Vesting period of shares (in years) | 12 months | | | |
Shares Vested, Directors (in hundredths) | 100.00% | | | |
Shares outstanding (in shares) | 25,398 | | | |
Cost | 186,000 | 158,000 | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, beginning balance (in shares) | 23,220 | | | 23,220 |
Granted (in shares) | 25,398 | 23,220 | | |
Cancelled/Forfeited (in shares) | 0 | | | |
Vested (in shares) | -23,220 | | | |
Nonvested shares outstanding, ending balance (in shares) | 25,398 | | | |
Additional disclosures [Abstract] | | | | |
Fair value of shares issued | $700,000 | $600,000 | | |
Director | Grant Date January 2015 | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Shares outstanding (in shares) | 25,398 | | | |
Fair value per share (in dollars per share) | $29.34 | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Nonvested shares outstanding, ending balance (in shares) | 25,398 | | | |
Additional disclosures [Abstract] | | | | |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $29.34 | | | |
Minimum | Officers and Key Employees | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Percentage of actual amount of shares that ultimately vest of original share units granted | 0.00% | | | |
Maximum | Officers and Key Employees | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Percentage of actual amount of shares that ultimately vest of original share units granted | 200.00% | | | |
Stock Appreciation Rights (SARs) | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Number of shares granted | 0 | 0 | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Granted (in shares) | 0 | 0 | | |
Restricted Stock | Officers and Key Employees | | | | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | | | | |
Number of shares granted | | | | 45,406 |
Vesting period of shares (in years) | 3 years | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Payout Limit, Percentage | 100.00% | | | |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | | | | |
Granted (in shares) | | | | 45,406 |